...
首页> 外文期刊>Oral oncology >Clinical implications of pathologic factors after thyroid lobectomy in patients with papillary thyroid carcinoma
【24h】

Clinical implications of pathologic factors after thyroid lobectomy in patients with papillary thyroid carcinoma

机译:病理因子在乳头状甲状腺癌患者甲状腺肺切除术后病理因子的临床意义

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Highlights ? micro-ETE was an important prognostic factor associated with RFS. ? The 10-year RFS was 99.2% for patients without ETE. ? The 10-year RFS was 92.2% for patients with micro-ETE. ? Appropriate US follow-up should be required in patients with the risk factors. Abstract Objective We evaluated the clinical and prognostic significance of pathologic factors by analyzing the treatment results of patients who underwent thyroid lobectomy. Materials and methods We retrospectively analyzed data from 734 patients diagnosed with papillary thyroid cancer who underwent thyroid lobectomy at Korea University Hospital from January 2004 to December 2016. Results A total of 734 patients were included in the study and their mean age was 44.5 years (range, 15–83). On univariate analysis, tumor size and recurrence-free survival were significantly related. The 10-year recurrence-free survival was 98.3% for tumors ≤1cm, 77.8% for >1cm and ≤2cm, and 66.7% for >2cm (p = 0.014). Recurrence-free survival was significantly different between patients with and without microscopic extrathyroidal extension (p=0.002). The 10-year recurrence-free survival rate was 99.2% for patients without extrathyroidal extension and 92.2% for patients with microscopic extrathyroidal extension. Multivariate analysis showed only microscopic extrathyroidal extension was significantly correlated with recurrence-free survival (p=0.029). Conclusion In patients undergoing thyroid lobectomy for low-risk papillary thyroid cancer, microscopic extrathyroidal extension was an important prognostic factor associated with recurrence-free survival. However, in cases with microscopic extrathyroidal extension findings on postoperative pathologic examination, appropriate ultrasonographic follow-up of the contralateral thyroid lobe and cervical lymph node to facilitate early detection and prompt treatment of recurrence can control the disease without a deterioration of survival rate.
机译:强调 ? Micro-ete是与RF相关的重要预后因子。还没有Eete的患者,10年的RFS为99.2%。还微型仪表患者,10年的RFS为92.2%。还患者风险因素的患者应需要适当的美国随访。摘要目的我们通过分析接受甲状腺肺切除术的患者的治疗结果来评估病理因素对病理因素的临床和预后意义。我们回顾性分析了734例患有乳头状甲状腺癌的734名患者的数据,在2004年1月至2016年12月在韩国大学医院接受了甲状腺乳腺切除术。结果共有734名患者纳入研究,其平均年龄为44.5岁(范围,15-83)。关于单变量分析,肿瘤大小和无复发的存活率显着相关。肿瘤的10年的复发存活率为98.3%,肿瘤≤1cm,77.8%> 1cm,≤2cm,66.7%> 2cm(p = 0.014)。在没有显微镜脱滴虫延伸的患者之间,无复发的存活率显着差异(P = 0.002)。对于无脱滴虫延长的患者,10年的复发存活率为99.2%,微观脱滴虫延伸的患者为92.2%。多变量分析显示显微镜脱水延伸与无复发存活率显着相关(P = 0.029)。结论在接受低危乳头状甲状腺癌的甲状腺肺切除术患者中,微观脱滴虫延伸是一种与无复发存活相关的重要预后因子。然而,在术后病理检查的微观脱滴虫延伸结果的情况下,对侧甲状腺叶和宫颈淋巴结的适当超声再次随访,以促进早期检测和迅速治疗复发,可以控制疾病而不会恶化存活率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号